{"id":"https://openalex.org/W2094123743","doi":"https://doi.org/10.1016/0049-3848(96)00085-0","title":"Effects of a highly selective synthetic inhibitor of plasma kallikrein on disseminated intravascular coagulation in rats","display_name":"Effects of a highly selective synthetic inhibitor of plasma kallikrein on disseminated intravascular coagulation in rats","alternate_titles":[],"publication_year":1996,"publication_date":"1996-05-01","ids":{"openalex":"https://openalex.org/W2094123743","doi":"https://doi.org/10.1016/0049-3848(96)00085-0","mag":"2094123743","pmid":"https://pubmed.ncbi.nlm.nih.gov/8743731"},"language":"en","primary_location":{"id":"doi:10.1016/0049-3848(96)00085-0","doi":"https://doi.org/10.1016/0049-3848(96)00085-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0049-3848(96)00085-0","pdf_url":null,"source":{"id":"https://openalex.org/S134546602","display_name":"Thrombosis Research","issn_l":"0049-3848","issn":["0049-3848","1879-2472"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2094123743"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026693711","display_name":"Yasuhiro Katsuura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25222733","display_name":"Showa Denko (Japan)","ror":"https://ror.org/0251vfx90","country_code":"JP","type":"company","lineage":["https://openalex.org/I25222733","https://openalex.org/I4388891786"]},{"id":"https://openalex.org/I90469020","display_name":"Teijin (Japan)","ror":"https://ror.org/038kxkq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I90469020"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yasuhiro Katsuura","raw_affiliation_strings":["Life Science Research Laboratory, Showa Denko K.K., Tokyo, Japan","Life Science Research Laboratory, Showa Denko K.K., 2-24-25, Tamagawa, Ohta-ku, Tokyo 147, Japan","Pharmaceuticals Development Research Laboratories, Teijin Ltd. 4-3-2 Asahigaoka Hino Tokyo 191, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Life Science Research Laboratory, Showa Denko K.K., Tokyo, Japan","institution_ids":["https://openalex.org/I25222733"]},{"raw_affiliation_string":"Life Science Research Laboratory, Showa Denko K.K., 2-24-25, Tamagawa, Ohta-ku, Tokyo 147, Japan","institution_ids":["https://openalex.org/I25222733"]},{"raw_affiliation_string":"Pharmaceuticals Development Research Laboratories, Teijin Ltd. 4-3-2 Asahigaoka Hino Tokyo 191, Japan","institution_ids":["https://openalex.org/I90469020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111751626","display_name":"Shosuke Okamoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Shosuke Okamoto","raw_affiliation_strings":["Kobe Research Projects on Thrombosis and Haemostasis1, 3-15-18, Asahigaoka, Tarumi-ku, Kobe 655, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kobe Research Projects on Thrombosis and Haemostasis1, 3-15-18, Asahigaoka, Tarumi-ku, Kobe 655, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079116448","display_name":"Norio Ohno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25222733","display_name":"Showa Denko (Japan)","ror":"https://ror.org/0251vfx90","country_code":"JP","type":"company","lineage":["https://openalex.org/I25222733","https://openalex.org/I4388891786"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Norio Ohno","raw_affiliation_strings":["Life Science Research Laboratory, Showa Denko K.K., 2-24-25, Tamagawa, Ohta-ku, Tokyo 147, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Life Science Research Laboratory, Showa Denko K.K., 2-24-25, Tamagawa, Ohta-ku, Tokyo 147, Japan","institution_ids":["https://openalex.org/I25222733"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021607990","display_name":"Keiko Wanaka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Keiko Wanaka","raw_affiliation_strings":["Kobe Research Projects on Thrombosis and Haemostasis1, 3-15-18, Asahigaoka, Tarumi-ku, Kobe 655, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kobe Research Projects on Thrombosis and Haemostasis1, 3-15-18, Asahigaoka, Tarumi-ku, Kobe 655, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5111751626"],"corresponding_institution_ids":[],"apc_list":{"value":4080,"currency":"USD","value_usd":4080},"apc_paid":null,"fwci":0.4454,"has_fulltext":false,"cited_by_count":7,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.59070918,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"82","issue":"4","first_page":"361","last_page":"368"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11116","display_name":"Trauma, Hemostasis, Coagulopathy, Resuscitation","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/plasma-kallikrein","display_name":"plasma kallikrein","score":0.9279999732971191},{"id":"https://openalex.org/keywords/kallikrein-inhibitor","display_name":"kallikrein inhibitor","score":0.8980000019073486},{"id":"https://openalex.org/keywords/disseminated-intravascular-coagulation","display_name":"disseminated intravascular coagulation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/organ-failure","display_name":"organ failure","score":0.7910000085830688},{"id":"https://openalex.org/keywords/fibrinolysis","display_name":"fibrinolysis","score":0.828000009059906},{"id":"https://openalex.org/keywords/fibrinogen-degradation-products","display_name":"fibrinogen degradation products","score":0.8989999890327454},{"id":"https://openalex.org/keywords/platelet-count","display_name":"platelet count","score":0.6700000166893005}],"concepts":[{"id":"https://openalex.org/C2778734968","wikidata":"https://www.wikidata.org/wiki/Q823027","display_name":"Disseminated intravascular coagulation","level":2,"score":0.7938331365585327},{"id":"https://openalex.org/C2779036427","wikidata":"https://www.wikidata.org/wiki/Q381899","display_name":"Fibrinogen","level":2,"score":0.703357458114624},{"id":"https://openalex.org/C2776825266","wikidata":"https://www.wikidata.org/wiki/Q1410794","display_name":"Fibrinolysis","level":2,"score":0.6475179195404053},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6286777257919312},{"id":"https://openalex.org/C54173615","wikidata":"https://www.wikidata.org/wiki/Q27205","display_name":"Fibrin","level":2,"score":0.6157724261283875},{"id":"https://openalex.org/C52853521","wikidata":"https://www.wikidata.org/wiki/Q423285","display_name":"Kallikrein","level":3,"score":0.5342499613761902},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5222949981689453},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.5198484063148499},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.46060046553611755},{"id":"https://openalex.org/C2776877979","wikidata":"https://www.wikidata.org/wiki/Q424288","display_name":"Transaminase","level":3,"score":0.438819020986557},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4158092141151428},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4013752341270447},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3382982611656189},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2800799608230591},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20568126440048218},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.16053524613380432}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001777","descriptor_name":"Blood Coagulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005338","descriptor_name":"Fibrin Fibrinogen Degradation Products","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D005340","descriptor_name":"Fibrinogen","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007610","descriptor_name":"Kallikreins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010649","descriptor_name":"Phenylalanine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010649","descriptor_name":"Phenylalanine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010976","descriptor_name":"Platelet Count","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014148","descriptor_name":"Tranexamic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014148","descriptor_name":"Tranexamic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D015842","descriptor_name":"Serine Proteinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0049-3848(96)00085-0","doi":"https://doi.org/10.1016/0049-3848(96)00085-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0049-3848(96)00085-0","pdf_url":null,"source":{"id":"https://openalex.org/S134546602","display_name":"Thrombosis Research","issn_l":"0049-3848","issn":["0049-3848","1879-2472"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis Research","raw_type":"journal-article"},{"id":"pmid:8743731","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8743731","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W41549515","https://openalex.org/W176473613","https://openalex.org/W178589946","https://openalex.org/W197586874","https://openalex.org/W1493889956","https://openalex.org/W1575346591","https://openalex.org/W1981924181","https://openalex.org/W1987709405","https://openalex.org/W2036688878","https://openalex.org/W2052610201","https://openalex.org/W2055247291","https://openalex.org/W2065051647","https://openalex.org/W2067826911","https://openalex.org/W2078187543","https://openalex.org/W2081547702","https://openalex.org/W2086232516","https://openalex.org/W2091910916","https://openalex.org/W2094263097","https://openalex.org/W2107269020","https://openalex.org/W2109782036","https://openalex.org/W2144694645","https://openalex.org/W2160388336","https://openalex.org/W2319840877","https://openalex.org/W2332297603","https://openalex.org/W2407866941","https://openalex.org/W2412312642","https://openalex.org/W2417196173","https://openalex.org/W4291319092","https://openalex.org/W4313310011"],"related_works":["https://openalex.org/W1987709405","https://openalex.org/W2009049327","https://openalex.org/W2413214334","https://openalex.org/W1985402468","https://openalex.org/W2028244257","https://openalex.org/W2312480047","https://openalex.org/W2368876630","https://openalex.org/W2946512028","https://openalex.org/W2409088864","https://openalex.org/W2408309726"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2094123743","counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}
